PMID- 9557853 OWN - NLM STAT- MEDLINE DCOM- 19980615 LR - 20190512 IS - 0268-1161 (Print) IS - 0268-1161 (Linking) VI - 13 IP - 2 DP - 1998 Feb TI - Induction of inducible nitric oxide synthase expression in human secretory endometrium. PG - 436-44 AB - The endometrial secretory phase is characterized by stromal oedema, a premenstrual increase in stromal macrophages and an increased cytokine production as menstruation approaches. Nitric oxide (NO) is a mediator of vasodilatation and cytotoxicity which is synthesized from L-arginine by NO synthases (NOS). These enzymes are either constitutively expressed or induced by lipopolysaccharides and/or cytokines. The presence and function of the inducible isoform of NOS (iNOS) in normal human endometrium has not been fully elucidated until recently. Frozen tissue sections taken from 22 women who underwent hysterectomy and adnexectomy for benign disease were immunostained with antibodies raised against the different NOS isoforms to investigate the presence of NOS in human endometrium. iNOS stained positive in the glandular epithelial cells of the secretory endometrium. Staining was either weak or absent in the proliferative and inactive endometrium, as well as in the oviduct and the glandular epithelium of the endocervix. The stroma remained uniformly negative. Immunoreactivity for endothelial constitutive NOS (eNOS) was confined exclusively to endothelial cells. Furthermore, epithelial cells from endometrium, oviduct and endocervix and all endothelial cells showed positive staining for reduced nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase, which is a histochemical marker for NOS activity. Reverse transcriptase polymerase chain reaction (RT-PCR) was performed in order to assess the presence of NOS mRNA. Abundant expression of iNOS mRNA was detected in the secretory phase endometrium only. The strong expression of inducible NO synthase in human secretory phase endometrium suggests that the increased production of NO, probably induced by cytokines, may be relevant to the process of menstruation. FAU - Tschugguel, W AU - Tschugguel W AD - Department of Gynaecology and Obstetrics, University of Vienna, School of Medicine, Austria. FAU - Schneeberger, C AU - Schneeberger C FAU - Unfried, G AU - Unfried G FAU - Czerwenka, K AU - Czerwenka K FAU - Weninger, W AU - Weninger W FAU - Mildner, M AU - Mildner M FAU - Bishop, J R AU - Bishop JR FAU - Huber, J C AU - Huber JC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Hum Reprod JT - Human reproduction (Oxford, England) JID - 8701199 RN - 0 (DNA Primers) RN - 0 (RNA, Messenger) RN - EC 1.14.13.39 (NOS2 protein, human) RN - EC 1.14.13.39 (NOS3 protein, human) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type III) SB - IM EIN - Hum Reprod 1998 May;13(5):1414 MH - Base Sequence MH - DNA Primers/genetics MH - Endometrium/anatomy & histology/*enzymology/metabolism MH - Enzyme Induction MH - Epithelium/enzymology MH - Female MH - Follicular Phase/metabolism MH - Gene Expression MH - Humans MH - Immunohistochemistry MH - In Vitro Techniques MH - Luteal Phase/metabolism MH - Menstruation/metabolism MH - Nitric Oxide Synthase/*biosynthesis/*genetics MH - Nitric Oxide Synthase Type II MH - Nitric Oxide Synthase Type III MH - Polymerase Chain Reaction MH - RNA, Messenger/genetics/metabolism EDAT- 1998/04/29 00:00 MHDA- 1998/04/29 00:01 CRDT- 1998/04/29 00:00 PHST- 1998/04/29 00:00 [pubmed] PHST- 1998/04/29 00:01 [medline] PHST- 1998/04/29 00:00 [entrez] AID - 10.1093/humrep/13.2.436 [doi] PST - ppublish SO - Hum Reprod. 1998 Feb;13(2):436-44. doi: 10.1093/humrep/13.2.436.